Publicaties
Gilteritinib post TKI (2022)
Publicatie
Clinical outcomes in patients with relapsed/refractory FLT3- mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib.
Lees meerAML ELN guidance (2022)
Publicatie
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
Lees meerADMIRAL trial (2019)
Publicatie
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Lees meerNascholing & Congressen
Gilteritinib update (2022)
Publicatie
Post-hoc analyse om de werkzaamheid van gilteritinib na eerder FLT3-TKI gebruik te onderzoeken. NTvH 2022
Lees meer